News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
281,869 Results
Type
Article (14483)
Company Profile (46)
Press Release (267334)
Multimedia
Podcasts (32)
Webinars (10)
Section
Business (81927)
Career Advice (673)
Deals (11583)
Drug Delivery (67)
Drug Development (43521)
Employer Resources (69)
FDA (5584)
Job Trends (6911)
News (140699)
Policy (11820)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (1)
2027 Genetown Standard (2)
2027 Pharm Country Standard (2)
Academia (1368)
Academic (1)
Accelerated approval (42)
ADA (31)
Adcomms (7)
Allergies (113)
Alliances (21438)
ALS (145)
Alzheimer's disease (981)
Antibody-drug conjugate (ADC) (308)
Approvals (5814)
Artificial intelligence (332)
ASCO (194)
Autoimmune disease (242)
Automation (19)
Bankruptcy (113)
Best Places to Work (5915)
BIO (38)
BIOSECURE Act (6)
Biosimilars (68)
Biotechnology (37)
Bladder cancer (111)
Brain cancer (50)
Breast cancer (410)
Cancer (3589)
Cardiovascular disease (260)
Career advice (553)
Career pathing (21)
CAR-T (230)
CDC (23)
Celiac Disease (1)
Cell therapy (597)
Cervical cancer (21)
Clinical research (39363)
Collaboration (1273)
Company closure (4)
Compensation (511)
Complete response letters (32)
COVID-19 (1126)
CRISPR (72)
C-suite (727)
Cystic fibrosis (107)
Data (5296)
Decentralized trials (1)
Denatured (2)
Depression (119)
Dermatology (61)
Diabetes (353)
Diagnostics (2029)
Digital health (20)
Diversity (4)
Diversity, equity & inclusion (23)
Drug discovery (211)
Drug pricing (126)
Drug shortages (6)
Duchenne muscular dystrophy (206)
Earnings (35439)
Editorial (31)
Employer branding (9)
Employer resources (61)
Events (46014)
Executive appointments (573)
FDA (7782)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (25)
Funding (1178)
Gene editing (176)
Generative AI (30)
Gene therapy (551)
GLP-1 (573)
Government (2215)
Grass and pollen (1)
Guidances (251)
Healthcare (9301)
Hematology (103)
HIV (62)
Huntington's disease (36)
IgA nephropathy (82)
Immunology and inflammation (185)
Immuno-oncology (69)
Indications (137)
Infectious disease (1297)
Inflammatory bowel disease (149)
Inflation Reduction Act (10)
Influenza (66)
Intellectual property (196)
Interviews (71)
IPO (6542)
IRA (44)
Job creations (1198)
Job search strategy (489)
JPM (33)
Kidney cancer (16)
Labor market (34)
Layoffs (330)
Leadership (13)
Legal (1616)
Liver cancer (53)
Longevity (19)
Lung cancer (450)
Lymphoma (272)
Machine learning (43)
Management (27)
Manufacturing (508)
Marketing (2)
MASH (147)
Medical device (3366)
Medtech (3415)
Mergers & acquisitions (5531)
Metabolic disorders (934)
mRNA (140)
Multiple sclerosis (145)
NASH (15)
Neurodegenerative disease (302)
Neuropsychiatric disorders (69)
Neuroscience (2042)
Neurotech (1)
NextGen: Class of 2026 (3096)
Non-profit (3255)
Now hiring (25)
Obesity (395)
Opinion (131)
Ovarian cancer (157)
Pain (131)
Pancreatic cancer (216)
Parkinson's disease (261)
Partnered (18)
Patents (319)
Patient recruitment (471)
Peanut (35)
People (25875)
Pharmaceutical (10)
Pharmacy benefit managers (15)
Phase 1 (12691)
Phase 2 (17768)
Phase 3 (13309)
Pipeline (6372)
Policy (161)
Postmarket research (740)
Preclinical (5088)
Press Release (16)
Prostate cancer (189)
Psychedelics (33)
Radiopharmaceuticals (218)
Rare diseases (795)
Real estate (1691)
Recruiting (27)
Regulatory (10972)
Reports (15)
Research institute (1178)
Resumes & cover letters (146)
Rett syndrome (38)
RNA editing (18)
RSV (33)
Schizophrenia (115)
Series A (202)
Series B (150)
Service/supplier (1)
Sickle cell disease (90)
Special edition (6)
Spinal muscular atrophy (120)
Sponsored (20)
Startups (1587)
Stomach cancer (7)
Supply chain (29)
Tariffs (25)
The Weekly (29)
Vaccines (483)
Venture capital (62)
Weight loss (233)
Women's health (60)
Worklife (6)
Date
Today (29)
Last 7 days (269)
Last 30 days (1434)
Last 365 days (16350)
2026 (8888)
2025 (15334)
2024 (16937)
2023 (19682)
2022 (22508)
2021 (25135)
2020 (23588)
2019 (21146)
2018 (16068)
2017 (13496)
2016 (12044)
2015 (13926)
2014 (9593)
2013 (7206)
2012 (7669)
2011 (8346)
2010 (7357)
Location
Africa (259)
Alabama (50)
Alaska (3)
Arizona (117)
Arkansas (6)
Asia (14377)
Australia (3139)
California (7268)
Canada (1753)
China (605)
Colorado (246)
Connecticut (374)
Delaware (227)
Europe (40264)
Florida (1087)
Georgia (209)
Hawaii (2)
Idaho (18)
Illinois (527)
India (33)
Indiana (296)
Iowa (10)
Japan (355)
Kansas (43)
Kentucky (17)
Louisiana (28)
Maine (7)
Maryland (745)
Massachusetts (5869)
Michigan (92)
Minnesota (237)
Mississippi (3)
Missouri (68)
Montana (11)
Nebraska (13)
Nevada (50)
New Hampshire (27)
New Jersey (1741)
New Mexico (9)
New York (2254)
North Carolina (861)
North Dakota (5)
Northern California (3762)
Ohio (220)
Oklahoma (10)
Oregon (13)
Pennsylvania (1456)
Puerto Rico (9)
Rhode Island (17)
South America (362)
South Carolina (28)
South Dakota (2)
Southern California (2826)
Tennessee (83)
Texas (1147)
United States (25492)
Utah (151)
Virginia (161)
Washington D.C. (35)
Washington State (649)
Wisconsin (50)
281,869 Results for "encorps teachers program".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Nuvectis, Haisco ink up to $1.4B deal for two late-stage programs
China’s Haisco Pharmaceutical continues to wield deals, this time out-licensing rights to two late-stage programs to New Jersey biotech Nuvectis.
June 22, 2026
·
2 min read
·
Gabrielle Masson
Regulatory
Stakeholders want Makary’s voucher program paused, call for FDA independence
The FDA hasn’t been transparent and open enough with how it has implemented the Commissioner’s National Priority Voucher program, patient, industry and trade groups said Thursday.
June 5, 2026
·
3 min read
·
Tristan Manalac
Regulatory
FDA’s new voucher program hints at broader policy agenda, making many ‘uncomfortable’
While drugmakers and other stakeholders want to see faster approvals, experts say the FDA’s Commissioner’s National Priority Voucher program is still bereft of important details, with candidate selection and interference from the agency’s senior leaders topping the list.
June 19, 2026
·
7 min read
·
Michael Gibney
Series A
Tortugas takes neuro deep dive with $106M to develop Eisai, Hansoh programs
With programs from Eisai and Hansoh Pharmaceutical in hand, Tortugas Neuroscience has emerged with hopes of delivering daily oral treatments to patients with central nervous system conditions.
April 21, 2026
·
1 min read
·
Gabrielle Masson
Business
11 Startups Selected for National Life Sciences Accelerator Program
Of the 11 companies participating in the spring cohorts of the Drive program run by MassBio and SCbio, eight have locations in Massachusetts. One cohort focuses on biotech and the other on biomarkers and diagnostics.
April 1, 2026
·
2 min read
·
Angela Gabriel
Approvals
Novo’s High Dose Wegovy Scores FDA Priority Voucher Program’s 4th Nod
With the approval of Wegovy HD, Novo Nordisk joins Johnson & Johnson, Boehringer Ingelheim and USAntibiotics as beneficiaries of the FDA’s Commissioner’s National Priority Voucher program, which aims to review products that align with certain national priorities in less than two months.
March 19, 2026
·
2 min read
·
Heather McKenzie
Press Releases
Battelle Funds 16 Central Ohio STEM Programs Serving 14,000 Youth
June 15, 2026
·
5 min read
Manufacturing
FDA Launches PreCheck Program, Intended To Bring Manufacturers Home
The program will allow for frequent communication with the FDA, giving manufacturers timely input and guidance regarding the design of their facilities.
February 2, 2026
·
2 min read
·
Tristan Manalac
FDA
9 Months In, FDA’s New Priority Voucher Program Still Clouded With Uncertainty
The FDA’s Commissioner’s National Priority Voucher program, unveiled in June 2025, is “shrouded in secrecy,” Democratic representative Jake Auchincloss said last month, as regulatory and biopharma leaders try to decode the criteria for investigational or approved drugs to receive a voucher.
March 23, 2026
·
7 min read
·
Heather McKenzie
Press Releases
Satellos to Present Clinical Program Updates at ICNMD 2026
June 25, 2026
·
5 min read
1 of 28,187
Next
